Cosmos Health (COSM) Net Margin (2014 - 2026)
Cosmos Health's (COSM) quarterly Net Margin came in at 15.65% in Q1 2026, down 968.0% YoY from 1.8% in Q1 2025, and down 212.07% on a QoQ basis from 13.96% in Q4 2025.
Cosmos Health (COSM) Net Margin (2014 - 2026) Analysis & Trends
Cosmos Health (COSM) has 12 years of Net Margin data on file, last reported at 15.65% in Q1 2026.
- Quarterly Net Margin fell 968.0% year-over-year to 15.65% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 289.28% (down 24945.0% YoY) and the FY2025 annual result came in at 890.26%, down 84914.0% from the prior year.
- Net Margin slipped to 15.65% in Q1 2026, from 13.96% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 13.96% in Q4 2025 to a low of 132.44% in Q4 2023.
- A 5-year average of 31.16% and a median of 19.18% in 2025 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2023 — Net Margin sank 6398 bps — and 2025, when it surged 8105 bps.
- Tracing COSM's Net Margin over 5 years: stood at 68.45% in 2022, then plunged by 93 bps to 132.44% in 2023, then jumped by 49 bps to 67.09% in 2024, then surged by 121 bps to 13.96% in 2025, then tumbled by 212 bps to 15.65% in 2026.
- The last three Net Margin figures came in at 15.65% (Q1 2026), 13.96% (Q4 2025), and 31.28% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 0.98% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 0.92% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 0.63% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 2.98% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -109.73% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -14.52% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -1.57% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -32.06% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 0.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.65% |
| Dec 31, 2025 | 13.96% |
| Sep 30, 2025 | -31.28% |
| Jun 30, 2025 | -19.18% |
| Mar 31, 2025 | -5.97% |
| Dec 31, 2024 | -67.09% |
| Sep 30, 2024 | -67.50% |
| Jun 30, 2024 | -19.62% |
| Mar 31, 2024 | -12.80% |
| Dec 31, 2023 | -132.44% |
| Sep 30, 2023 | -26.23% |
| Jun 30, 2023 | -7.94% |
| Mar 31, 2023 | -3.72% |
| Dec 31, 2022 | -68.45% |
| Sep 30, 2022 | -13.27% |
| Jun 30, 2022 | -9.25% |
| Mar 31, 2022 | -43.23% |
| Dec 31, 2021 | -9.10% |
| Sep 30, 2021 | -14.24% |
| Jun 30, 2021 | -16.02% |